These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 580840)

  • 1. Ocular hypertension. II. A carbonic anhydrase inhibitor test for early detection of glaucoma.
    Linnér E
    Acta Ophthalmol (Copenh); 1978 Apr; 56(2):179-90. PubMed ID: 580840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
    Gelatt KN; Gum G; Williams LW; Gwin RM
    Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database.
    Lafuma A; Berdeaux G
    Curr Med Res Opin; 2008 May; 24(5):1519-27. PubMed ID: 18413015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising complexes of acetazolamide for topical ocular administration.
    Granero GE; Longhi MR
    Expert Opin Drug Deliv; 2010 Aug; 7(8):943-53. PubMed ID: 20565335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice.
    Gulati S; Aref AA
    Expert Rev Clin Pharmacol; 2021 Aug; 14(8):955-961. PubMed ID: 34003717
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
    Antonaroli S; Bianco A; Brufani M; Cellai L; Lo Baido G; Potier E; Bonomi L; Perfetti S; Fiaschi AI; Segre G
    J Med Chem; 1992 Jul; 35(14):2697-703. PubMed ID: 1635066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits.
    Stein A; Pinke R; Krupin T; Glabb E; Podos SM; Serle J; Maren TH
    Am J Ophthalmol; 1983 Feb; 95(2):222-8. PubMed ID: 6824053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients.
    Fogagnolo P; Centofanti M; Figus M; Frezzotti P; Fea A; Ligorio P; Lembo A; Digiuni M; Lorenzi U; Rossetti L
    Ophthalmologica; 2012; 228(3):154-8. PubMed ID: 22572718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVOIDANCE OF SIDE-REACTIONS AND LOSS OF DRUG EFFICACY DURING LONG-TERM ADMINISTRATION OF CARBONIC ANHYDRASE INHIBITORS BY CONCOMITANT SUPPLEMENTAL ELECTROLYTE ADMINISTRATION.
    DRAEGER J; GRUETTNER R; THEILMANN W
    Br J Ophthalmol; 1963 Aug; 47(8):457-68. PubMed ID: 14196143
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension?
    Gupta A; Vernon SA
    Eye (Lond); 2015 Oct; 29(10):1299-307. PubMed ID: 25697456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V; Jain NK
    Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure.
    Meredith SP; Swift L; Eke T; Broadway DC
    J Glaucoma; 2007 Sep; 16(6):556-61. PubMed ID: 17873718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local action of the carbonic anhydrase inhibitor, acetazoleamide, on the intraocular pressure in cats.
    WISTRAND P
    Acta Pharmacol Toxicol (Copenh); 1957; 14(1):27-37. PubMed ID: 13469427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.